Nirmatrelvir and ritonavir combination against COVID ‐19 caused by omicron BA.2.2 in the elderly: A single‐center large observational study

ConclusionsThese findings suggest that administering nirmatrelvir –ritonavir within 10 days of symptom onset could potentially reduce the time it takes for SARS-CoV-2-infected patients to negative RT-PCR results, thereby expanding the current usage guidelines for nirmatrelvir–ritonavir.

https://onlinelibrary.wiley.com/doi/10.1002/iid3.1232?af=R

Source: Immunity, Inflammation and Disease - April 5, 2024 Category: Allergy & Immunology Authors: Can Chen, Ranyi Li, Shuliang Xing, Lei Cao, Yue Qu, Qianzhou Lv, Xiaoyu Li, Zhangzhang Chen Tags: ORIGINAL ARTICLE Source Type: research